@article{article, title  = {{Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial}},

 url = {{}},

 year = {{2021}},

 month = {{4}},

 author = {{von Herrath M and Bain SC and Bode B and Clausen JO and Coppieters K and Gaysina L and Gumprecht J and Hansen TK and Mathieu C and Morales C and Mosenzon O et al}},

 doi = {{10.1016/S2213-8587(21)00019-X}},

 volume = {{9}},

 journal = {{The Lancet Diabetes and Endocrinology}},

 issue = {{4}},

 pages = {{212-224}},

 note = {{Accessed on 2024/10/22}}}